The baseline patient characteristics for all subgroups analyzed are shown in Table S1 . Tables  S2-S6 demonstrate the association between ECG metrics and cardiovascular death (CVD) in the validation cohort and low-risk subgroups, adjusting by TRS, LVEF and BNP as appropriate. None of the ECG metrics were significantly associated with CVD in a higher-risk subgroup (TRS≥5 , Table S7 ).
Supplemental Tables   Table S1: Baseline patient characteristics for whole dataset (MERLIN placebo) and subpopulations. *: statistically significant difference (at the 5% level) compared to the validation cohort. Table S10 : AUC and Category-free Net Reclassification Index (cfNRI) comparing addition of MVB to models incorporating TRS, LVEF, and BNP as appropriate. Since meaningful improvements in discrimination can be masked by small changes in AUC, 1 the statistical difference in the model was quantified by reclassification. 95% confidence intervals (CI) were computed using a nonparametric stratified bootstrap approach with 2000 repeats. *The small number of events in this population made it difficult to reach convergence in the logistic regression models. Figure S1 : Optimizing the diagnostic beat-frequency for maximum AUC in the derivation cohort (DISPERSE2-TIMI 33 clinical trial, N=764). Figure 2 summarizes the procedure for computing Morphologic Variability in Beatspace (MVB). The input ECG signal converted into a beat-to-beat difference time series termed the Morphologic Distance (MD) time series. The MD time series is then segmented into 5-minute windows, transformed into the beatfrequency domain, and the energy in the diagnostic beat-frequency range is summed for each window. The 90 th percentile of these energies over all 5-minute windows in 24 hours is termed the MVB for the patient. This figure illustrates the procedure of optimizing the diagnostic beatfrequency. Each point represents the AUC for death within 90 days, computed using a diagnostic beat-frequency with lower and upper limits defined by the x-y axes. For example, the value of 0.73 (indicated by the arrow) means that a diagnostic beat-frequency of every 2 to 7 beats results in an AUC of 0.73. This is also the peak AUC; thus we define the optimal diagnostic beat-frequency to be every 2 to 7 beats. The inset illustrates the Receiver Operating Characteristic (ROC) curve for this optimal diagnostic beat-frequency.
